Has Nikhil Thakur, MD received payments from drug or device companies?

Yes. Drug and device makers reported $117,622 in general payments to Nikhil Thakur, MD across 383 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nikhil Thakur, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nikhil Thakur, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nikhil Thakur, MD

Orthopaedic Surgery of the Spine · North Andover, MANPI 1871710756

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $78,292 of the $117,622 with a category attached, or 66.6%. Stryker accounts for 67.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $25,262 and has fallen 68.7% since, to $7,904 in 2025.

$117,622in general payments, 2019–2025

Across 383 payments — averaging $307.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$79K
Expanding Innovations, Inc.$22K
Depuy Synthes Products, Inc.$5K
Medical Device Business Services, Inc.$5K
4web, Inc.$2K
Life Spine, Inc.$1K
plus $3K from 9 others

$22,335in ownership & investment interests, 2019–2025

Across 5 payments — averaging $4467.06 each. An ownership or investment interest held by the physician or an immediate family member.

Expanding Innovations, Inc.$22K

What the payments were for

Royalty or licence$17,23615%
Consulting fees$78,29267%
Travel & lodging$12,02810%
Food & beverage$9,8028%
Education$140%
Entertainment$2510%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	308	$79,066
Expanding Innovations, Inc.	8	$22,336
Depuy Synthes Products, Inc.	3	$5,166
Medical Device Business Services, Inc.	2	$4,626
4web, Inc.	11	$2,425
Life Spine, Inc.	3	$1,288
Abbott	30	$756
Spinal Elements, Inc.	2	$660
Ulrich Medical USA, Inc.	2	$382
Pacira Pharmaceuticals Incorporated	2	$355
Johnson & Johnson	5	$312
Painteq LLC	4	$98
Zimmer Biomet	1	$71
Canon Medical Systems USA, Inc.	1	$45
Boston Scientific	1	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$55,216
X-PAC$20,418
EXPEDIUM$9,766
SPINE TRUSS SYSTEM$2,000
XIA$1,594
XIA 3$809
PRO-LINK STAND-ALONE CERVICAL SPACER SYSTEM$784
Cervical Plage$784
Medical Device$660
ARx$392
EXPAREL$355
CASCADIA INTERBODY SYSTEM$283
NEW PRODUCT DEVELOPMENT$171
VITOSS$157
DENALI SPINAL SYSTEM$157
EVEREST SPINAL SYSTEM$150
PROCLAIM$137

How this compares

$117,622 in reported general payments places this provider in the 70th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$95,760

Medicare patients

Services billed

327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	37	$458
Gabapentin	12	$203

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in North Andover

Paul GlazerChestnut Hill$2.1M
Raymond HwangChestnut Hill$1.1M
Robert BancoWellesley Hills$661K
Mitchell HardenbrookHopedale$542K
Steven LeckiePlymouth$316K
Jeremy ShorePeabody$232K
Richard OzunaPeabody$198K
Chadi TannouryBoston$81K
Bryce BasquesRaynham$72K
Jason PittmanBoston$70K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →